Literature DB >> 12463738

Tumor-associated macrophages in breast cancer.

Russell D Leek1, Adrian L Harris.   

Abstract

Neoplastic cells form only one part of a complex network of cell types that make up a breast tumor. The normal cell types that make up the nonneoplastic components of tumors include fibroblasts, endothelium, and inflammatory cells, such as tumor associated macrophages (TAMs). TAMs have the potential to carry out both anti- and protumor activities In their antitumor role TAMs can present tumor antigens to cytotoxic T-cells and are capable of being directly cytotoxic to neoplastic cells. Conversely, TAMs are also able to promote tumor growth directly by secreting breast tumor mitogens, such as epidermal growth factor, and indirectly by stimulating tumor angiogenesis and metastasis. Recent studies have indicated that in breast cancers the protumor role of TAMs is dominant, and that TAMs may be executing a "wound healing" type of process in response to stimuli found in the tumor microenvironment, such as hypoxia. As such, TAMs may provide opportunities for future therapeutic interventions.

Entities:  

Mesh:

Year:  2002        PMID: 12463738     DOI: 10.1023/a:1020304003704

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  116 in total

1.  Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

Authors:  F Ciardiello; R Caputo; R Bianco; V Damiano; G Fontanini; S Cuccato; S De Placido; A R Bianco; G Tortora
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

2.  Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study.

Authors:  C Denoyelle; M Vasse; M Körner; Z Mishal; F Ganné; J P Vannier; J Soria; C Soria
Journal:  Carcinogenesis       Date:  2001-08       Impact factor: 4.944

Review 3.  HER-2/neu (c-erb-B2) gene and protein in breast cancer.

Authors:  J S Ross; J A Fletcher
Journal:  Am J Clin Pathol       Date:  1999-07       Impact factor: 2.493

Review 4.  Role of nitric oxide in tumour progression: lessons from human tumours.

Authors:  L L Thomsen; D W Miles
Journal:  Cancer Metastasis Rev       Date:  1998-03       Impact factor: 9.264

5.  Increased hyaluronidase levels in breast tumor metastases.

Authors:  P Bertrand; N Girard; C Duval; J d'Anjou; C Chauzy; J F Ménard; B Delpech
Journal:  Int J Cancer       Date:  1997-11-04       Impact factor: 7.396

6.  In vivo studies of macrophages and intercellular adhesion molecule-1 following lipopolysaccharide treatment in tumour-bearing rats.

Authors:  T M Nilsson; A E Woods; A M Rofe
Journal:  Immunol Cell Biol       Date:  1996-10       Impact factor: 5.126

Review 7.  Matrix metalloproteinase inhibitors.

Authors:  P D Brown
Journal:  Breast Cancer Res Treat       Date:  1998       Impact factor: 4.872

8.  The impact of extracellular matrix on the chemoresistance of solid tumors--experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy.

Authors:  G Baumgartner; C Gomar-Höss; L Sakr; E Ulsperger; C Wogritsch
Journal:  Cancer Lett       Date:  1998-09-11       Impact factor: 8.679

Review 9.  CSF-1 and its receptor in ovarian, endometrial and breast cancer.

Authors:  B M Kacinski
Journal:  Ann Med       Date:  1995-02       Impact factor: 4.709

10.  Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma.

Authors:  R A Walker; S J Dearing; B Gallacher
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more
  156 in total

1.  Genetic deletion of 5-lipoxygenase increases tumor-infiltrating macrophages in Apc(Δ468) mice.

Authors:  Eric C Cheon; Matthew J Strouch; Seth B Krantz; Michael J Heiferman; David J Bentrem
Journal:  J Gastrointest Surg       Date:  2011-11-10       Impact factor: 3.452

Review 2.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

Review 3.  Leukocytes in mammary development and cancer.

Authors:  Lisa M Coussens; Jeffrey W Pollard
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 4.  Metastasis: tumor cells becoming MENAcing.

Authors:  Frank Gertler; John Condeelis
Journal:  Trends Cell Biol       Date:  2010-11-09       Impact factor: 20.808

Review 5.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

6.  A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss.

Authors:  Alysia N Lozano-Ondoua; Courtney Wright; Anna Vardanyan; Tamara King; Tally M Largent-Milnes; Mark Nelson; Juan Miguel Jimenez-Andrade; Patrick W Mantyh; Todd W Vanderah
Journal:  Life Sci       Date:  2010-02-20       Impact factor: 5.037

7.  Cytokine comparisons between women with breast cancer and women with a negative breast biopsy.

Authors:  Debra E Lyon; Nancy L McCain; Jeanne Walter; Christine Schubert
Journal:  Nurs Res       Date:  2008 Jan-Feb       Impact factor: 2.381

8.  Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts.

Authors:  Daniele M Gilkes; Saumendra Bajpai; Pallavi Chaturvedi; Denis Wirtz; Gregg L Semenza
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

Review 9.  Circulating tumor cell interactions with macrophages: implications for biology and treatment.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Transl Lung Cancer Res       Date:  2017-08

10.  Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.

Authors:  Manuela Banciu; Josbert M Metselaar; Raymond M Schiffelers; Gert Storm
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.